drugset / Trial / NCT03961165

BUSCLAB - Buscopan to Prevent Slow Progress in Labor

NCT03961165

Phase 3 Completed 250 enrolled Oslo University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

To study the effect of Butylscopolamine Bromide on duration of the active phase of first stage of labor in first time mothers who cross the alert-line for labor dystocia, according to the WHO partograph.

Timeline

Start
2019-05-25
Primary completion
2021-08-29
Completion
2022-06-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyoscine butylbromide Unknown 20 mg Intravenous

Indications